Mandate

Vinge has advised the arrangers in connection with Heimstaden’s EUR 350,000,000 bond issuance

The banks acted as arrangers and bookrunners in connection with Heimstaden AB’s (publ) issuance of EUR 350,000,000 senior unsecured bonds, within a framework amount of EUR 450,000,000.

The bond proceeds are intended to be used for the purchase of equity in Heimstaden Bostad AB and general corporate purposes. In accordance with the terms and conditions, the bonds are intended to be listed on the corporate bond list of Nasdaq Stockholm.

Vinge’s team consisted of Louise Brorsson Salomon and Lionardo Ojeda (Banking and Finance) together with Jesper Schönbeck and Linnéa Sellström (Capital Markets and Public M&A).

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026